Uncovering a mammalian neural-specific poly(A) binding protein with unique properties

  1. Marc R. Fabian1,6,7
  1. 1Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada;
  2. 2Donnelly Centre, University of Toronto, Toronto, Ontario M5S 3E1, Canada;
  3. 3Department of Human Genetics, McGill University, Montreal, Quebec H3A 0G4, Canada;
  4. 4Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA;
  5. 5Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 3E1, Canada;
  6. 6Department of Biochemistry, McGill University, Montreal, Quebec H3A 0G4, Canada;
  7. 7Department of Oncology, McGill University, Montreal, Quebec H3A 0G4, Canada
  1. Corresponding author: marc.fabian{at}mcgill.ca

Abstract

The mRNA 3′ poly(A) tail plays a critical role in regulating both mRNA translation and turnover. It is bound by the cytoplasmic poly(A) binding protein (PABPC), an evolutionarily conserved protein that can interact with translation factors and mRNA decay machineries to regulate gene expression. Mammalian PABPC1, the prototypical PABPC, is expressed in most tissues and interacts with eukaryotic translation initiation factor 4G (eIF4G) to stimulate translation in specific contexts. In this study, we uncovered a new mammalian PABPC, which we named neural PABP (neuPABP), as it is predominantly expressed in the brain. neuPABP maintains a unique architecture as compared with other PABPCs, containing only two RNA recognition motifs (RRMs) and maintaining a unique N-terminal domain of unknown function. neuPABP expression is activated in neurons as they mature during synaptogenesis, where neuPABP localizes to the soma and postsynaptic densities. neuPABP interacts with the noncoding RNA BC1, as well as mRNAs coding for ribosomal and mitochondrial proteins. However, in contrast to PABPC1, neuPABP does not associate with actively translating mRNAs in the brain. In keeping with this, we show that neuPABP has evolved such that it does not bind eIF4G and as a result fails to support protein synthesis in vitro. Taken together, these results indicate that mammals have expanded their PABPC repertoire in the brain and propose that neuPABP may support the translational repression of select mRNAs.

Keywords

Footnotes

  • Received March 3, 2023.
  • Accepted August 29, 2023.

This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

| Table of Contents

Life Science Alliance